
|Articles|August 11, 2008
FDA is warning that patients should receive genetic testing before obtaining Ziagen
FDA warns about AIDS drug, abacavir, due to increased risk of potentially fatal side effects for some patients.
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
How Oral GLP-1 Medication Will Impact the Patient Medication Journey
2
Maternal Health Awareness Day: Advocacy, Policy Crucial for Protecting Access to Maternal Health
3
Congressional Spending Bill to Include Key PBM Contracting Reform
4
IRA Drug Price Negotiations Threatening Pharmacies’ Financial Sustainability
5
















